Skip to content
Skip to footer
Home
Platforms
► 2 Platforms
Complete360®
Valid-NEO®
Clinical Tests
► 4 Disease Categories
Research Services
► 6 Service Programs
Company
Our News
Our Leadership
Pioneering Publications
Our Process
Our Old Site
Contact Us
0 items
-
$0.00
0
0 items
-
$0.00
0
Valid-NEO
Close
Home
Platforms
► 2 Platforms
Complete360®
Valid-NEO®
Clinical Tests
► 4 Disease Categories
Research Services
► 6 Service Programs
Company
Our News
Our Leadership
Pioneering Publications
Our Process
Our Old Site
Contact Us
linkedin
facebook-1
twitter-x
instagram
Science. 2021 Mar5; 371(6533): eabc8697. Targeting a neoantigen derived from…
Valid-NEO
Science Advances. 2022 Jan 28;8(4):eabj3671. Identification of shared tumor epitopes…
Valid-NEO
Journal for Immunotherapy of Cancer. 2025 Aug 3;13(8):e010099. HERV-derived epitopes…
Valid-NEO
Blood Advances. 2022 Dec 9;7(9):1635–1649. Shared graft-versus-leukemia minor histocompatibility antigens…
Valid-NEO
Cancer Immunol Res . 2019 Nov;7(11):1748-1754. Direct Detection and Quantification of…
Valid-NEO
Cancers. 2022 Feb 28;14(5):1243. Valid-NEO: A Multi-Omics Platform for Neoantigen…
Valid-NEO
Science Immunology. 2021 Mar 1;6(57):eabd5515. Bispecific antibodies targeting mutant RAS…
Valid-NEO
Linkedin
Facebook
Twitter
Instagram
+1 410 215 2760
info@completeomics.com